Novo Nordisk A/S Sponsored ADR Logo

Novo Nordisk A/S Sponsored ADR (NVON)

BMV

Currency in MXN
791.23
+8.14 (+1.04%)

Real-time Data

02:30 PM

Day's Range

789.00
795.06

52 wk Range

637.43
1,140.00

Analyst Ratings - NVON - Novo Nordisk A/S Sponsored ADR

Analyst ratings

DateFirmActionRating
Mar 02, 2026Goldman SachsDowngradeBuy → Neutral
Feb 24, 2026JP MorganDowngradeOverweight → Neutral
Jan 09, 2026CICCInitiates coverageOutperform
Dec 08, 2025Argus ResearchDowngradeBuy → Hold
Nov 28, 2025Goldman SachsMaintainsBuy
Nov 25, 2025BMO CapitalMaintainsMarket Perform
Nov 24, 2025HSBCDowngradeBuy → Hold
Oct 14, 2025BMO CapitalMaintainsMarket Perform
Oct 02, 2025HSBCUpgradeHold → Buy
Sep 29, 2025Morgan StanleyDowngradeEqual-Weight → Underweight
Items per row:

Estimates - NVON - Novo Nordisk A/S Sponsored ADR

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - NVON - Novo Nordisk A/S Sponsored ADR

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-05-04-----
2026-04-09--0.07-0.08-0.01‪+14.29%‬
2025-12-03-0.270.45+0.18‪+66.67%‬
2025-11-13--0.500.13+0.63‪-126.00%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.